EUCTR2019-002452-16-NL进行中（未招募）1 期
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST-trial) - Anti-IgE in Atherosclerosis (MAST-trial)
MC Utrecht0 个研究点目标入组 80 人开始时间: 2020年2月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •(1) Patient is 18 years of age or older
- •(2) Patient is able and willing to give their consent and sign an informed consent
- •(3) Symptomatic or asymptomatic carotid artery stenosis based on atherosclerosis of at least 50% calculated by using criteria equivalent to the NASCET method
- •(4) Revascularization through carotid endarterectomy is indicated by multidisciplinary panel
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 16
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 64
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •(1) Previous anaphylactic reaction (e.g. food allergy, medication such as antibiotics etc.)
- •(2) Previous CEA or CAS in the ipsilateral artery
- •(3) Patients with severe asthma or chronic urticaria which are treated or have been treated with omalizumab s.c.
研究者
相似试验
进行中（未招募）
1 期
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST)MedDRA version: 24.1Level: LLTClassification code: 10029992Term: Occlusion and stenosis of carotid artery Class: 10029205MedDRA version: 21.1Level: LLTClassification code: 10081245Term: External carotid artery stenosis Class: 10029205MedDRA version: 20.0Level: PTClassification code: 10007687Term: Carotid artery stenosis Class: 100000004852MedDRA version: 21.1Level: LLTClassification code: 10081244Term: Internal carotid artery stenosis Class: 10029205Carotid artery stenosisCTIS2024-513581-19-00niversitair Medisch Centrum Utrecht40
尚未招募
2 期
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST-trial)carotid narrowingatherosclerotic carotid artery stenosis10003216NL-OMON54785niversitair Medisch Centrum Utrecht80
招募中
不适用
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST)Atherosclerotic narrowing of the carotid arteryNL-OMON23598ZonMW, Dutch Heart Foundation80
招募中
1 期
Clinical study for the treatment of atherosclerotic angiopathy with traditional Chinese MedicineatherosclerosisITMCTR1900002732Hebei Petro China Central Hospital
已完成
不适用
Prevention of atherosclerosis by SGLT2 inhibitor; multicenter, randomized controlled studyType 2 diabetesJPRN-UMIN000018440Department of Cardiovascular Medicine, Saga University479